Jupiter Neurosciences, Inc.
JUNS
$5.24
-$0.76-12.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.06M | -2.58M | -2.29M | -2.25M | -1.53M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 189.00K | 193.20K | 193.20K | 191.10K | 189.00K |
| Total Other Non-Cash Items | 631.20K | 403.80K | 1.01M | 528.50K | 421.50K |
| Change in Net Operating Assets | -190.40K | -390.10K | -65.00K | 705.10K | -144.70K |
| Cash from Operations | -1.43M | -2.37M | -1.15M | -828.20K | -1.06M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 5.58M | -- | -- | -- |
| Total Debt Repaid | -- | -146.40K | -- | -- | -- |
| Issuance of Common Stock | 5.50K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.50K | 5.43M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.43M | 3.07M | -1.15M | -828.20K | -1.06M |